Press release
NUTEX HEALTH PROVIDES UPDATE ON THE NO SURPRISES ACT
HOUSTON, March 27, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated

About this update from Nutex Health Inc.
[{"type":"text","content":"HOUSTON, March 27, 2023 /PRNewswire/ -- Nutex Health Inc. (\"Nutex Health\" or the \"Company\") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 20 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today provides an update on the No Surprises Act (\"NSA\").\nOn March 17, 2023, the Centers for Medicare & Medicaid Services (\"CMS\") issued new guidance (\"Guidance\") applicable to the independent dispute resolution (\"IDR\") process in the NSA effective for payment determinations made on or after February 6, 2023 for items and services furnished on or after October 25, 2022 for plan years (in the individual market, policy years) beginning on or after January 1, 2022. The revisions were put in place to help balance the arbitration process by including the recent Texas Medical Association Court Order and removing \"double counting\" provisions. From now on, independent arbiters must consider all evidence given to them by the disputing parties, and not just the Qualified Payment Amount (QPA). \nUnder the Guidance, Certified IDR Entities now must consider:\nQPA(s) for the applicable year for the qualified IDR item or service; andother information submitted by a party as long as it does not contain prohibited factors.Generally, parties may submit additional information regarding any of the circumstances of the services provided. Under the Guidance, the certified IDR entity now must consider all information submitted to determine the appropriate payment rate. Previously, there was a rebuttable presumption that the QPA was the appropriate payment amount, and the IDR entity was not required to consider any additional factors. This news comes as a major win for Nutex Health and other providers' quest to make the arbitration process more equitable and straightforward.\nAfter being suspended for services rendered after October 25, 2022, IDR entities have been instructed to resume payments. Now that the IDR process is reopened for all claims, arbiters can start making headway on the backlog.\n\"Nutex has always advocated for a fair payment system to providers so that we can continue to deliver high quality, efficient care to our patients. Having the insurers take into account all other factors, and not just the QPA, for provider payment...